I shared a cab ride with a cardiologist training in electrophysiology while I was attending the ACC14 in Washington, D.C. Talk about being in the right place at the right time.

When the Heart Rhythm Society’s scientific session kicks off next week, it likely will include a healthy contingent of presenters and attendees from outside the U.S. The international mix is especially beneficial in fields that depend on innovative technologies. 

The Heart Rhythm Society will name two winners of its Young Investigator Awards on May 9 at a ceremony during its 2014 annual scientific session in San Francisco.

An iPad 2 in close proximity of an implantable cardioverter-defibrillator (ICD) can trigger a magnet mode and potentially prevent therapeutic shocks, according to a study published online April 10 in the Journal of the American Heart Association.

John C. Lincoln North Mountain Hospital is the first in Arizona, and only one of eight hospitals in the U.S., to reduce or eliminate radiation for minimally invasive cardiac procedures utilizing MediGuide™ Technology.

Boston Scientific Corporation has conducted the first implant in the clinical trial of the next generation ACUITY™ X4 left-ventricular (LV) pacing leads and RELIANCE™ 4-FRONT defibrillation (ICD) leads. The clinical trial is designed to establish the safety and effectiveness of both lead families and is intended to support U.S. Food and Drug Administration (FDA) approval of these devices.

Two upcoming cardiovascular conferences are broadening their scope with programs that will help build electrophysiology teams and unify service lines.

Preregistration attendance for Heart Rhythm Society 2014 has increased significantly compared with last year in all demographic categories, said John D. Day, MD, chair of the scientific session program committee, with notable bumps in international physicians and allied professionals.